Risk of incident heart failure in individuals with early-onset type 2 diabetes
Liu JJ, Liu S, Wang J, et al.
J Clin Endocrinol Metab. 2022;107(1):e178-e18.
Leggi
Randomized trial of closed-loop control in very young children with type 1 diabetes
Ware J, Allen JM, Boughton CK, et al.
N Engl J Med. 2022;386(3):209-219.
Leggi
Obesity and chronic kidney disease in US Adults with type 1 and type 2 diabetes mellitus
Wallace AS, Chang AR, Shin JI, et al.
J Clin Endocrinol Metab. 2022;dgab927.
Leggi
Effects of Tirzepatide, a dual GIP and GLP-1 RA, on lipid and metabolite profiles in subjects with type 2 dabetes
Pirro V, Roth KD, Lin Y, et al.
J Clin Endocrinol Metab. 2022;107(2):363-378.
Leggi
The role of first-trimester HbA1c in the early detection of gestational diabetes
Valadan M, Bahramnezhad Z, Golshahi F, Feizabad E
BMC Pregnancy Childbirth. 2022;22(1):71.
Leggi
Gastric bypass versus sleeve gastrectomy in type 2 diabetes: effects on hepatic steatosis and fibrosis. A randomized controlled trial
Seeberg KA, Borgeraas H, Hofsø D, et al.
Ann Intern Med. 2022;175(1):74-83
Leggi
Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved trial
Butler J, Filippatos G, Siddiqi TJ, et al.
Circulation. 2022;145(3):184-193
Leggi
Serial assessment of high-sensitivity cardiac troponin and the effect of dapagliflozin in patients with heart failure with reduced ejection fraction: an analysis of the DAPA-HF trial
Berg DD, Docherty KF, Sattar N, et al.
Circulation. 2022;145(3):158-169
Leggi
Risk for newly diagnosed diabetes >30 Days After SARS-CoV-2 infection among persons aged <18 years - United States, March 1, 2020-June 28, 2021
Barrett CE, Koyama AK, Alvarez P, et al.
MMWR Morb Mortal Wkly Rep. 2022;71(2):59-65.
Leggi